Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Immuneering Corp as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −7 vs. Q4 2024
- Shares held
- 4.50M
- +196.1K (+4.6%) vs. Q4 2024
- Total value
- $6.84M
- −$2.49M (−26.7%) vs. Q4 2024
- New holders
- 5
- 9 more added
- Sold out
- 12
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,056,922 | $1.61M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 807,969 | $1.23M | 0.00% | +786,537+3,669.9% | Added |
| Price T Rowe Associates Inc | 659,009 | $1.00M | 0.00% | −108,115−14.1% | Reduced |
| Morgan Stanley | 467,226 | $710.2K | 0.00% | +13,126+2.9% | Added |
| BlackRock, Inc. | 316,530 | $481.1K | 0.00% | −2,233−0.7% | Reduced |
| Southport Management, L.L.C. | 245,000 | $372.4K | 1.61% | +30,000+14.0% | Added |
| Geode Capital Management, LLC | 225,817 | $343.3K | 0.00% | +17,430+8.4% | Added |
| HighTower Advisors, LLC | 83,960 | $127.6K | 0.00% | +12,600+17.7% | Added |
| Manufacturers Life Insurance Company, The | 82,667 | $125.7K | 0.00% | +290.0% | Added |
| State Street Corp | 78,535 | $119.4K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 71,066 | $108.0K | 0.00% | −79,810−52.9% | Reduced |
| Bridgeway Capital Management, LLC | 60,449 | $91.9K | 0.00% | +9,100+17.7% | Added |
| Tidemark, LLC | 44,400 | $67.5K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 39,729 | $60.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 35,757 | $54.4K | 0.00% | −14,800−29.3% | Reduced |
| First Manhattan Co | 32,325 | $49.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28,854 | $43.9K | 0.00% | −2,200−7.1% | Reduced |
| UBS Group AG | 28,551 | $43.4K | 0.00% | −23,942−45.6% | Reduced |
| Millennium Management LLC | 23,065 | $35.1K | 0.00% | −79,871−77.6% | Reduced |
| Jane Street Group, LLC | 20,869 | $31.7K | 0.00% | +20,869 | New |
| The PNC Financial Services Group, Inc. | 20,000 | $30.4K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 13,366 | $20.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 12,000 | $18.2K | 0.00% | +12,000 | New |
| Engineers Gate Manager LP | 10,607 | $16.1K | 0.00% | +10,607 | New |
| Barclays PLC | 9,924 | $15.1K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 10,000 | $12.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,328 | $9.62K | 0.00% | +3,928+163.7% | Added |
| Federated Hermes, Inc. | 3,954 | $6.01K | 0.00% | +116+3.0% | Added |
| JPMorgan Chase & Co | 1,974 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 796 | $1.21K | 0.00% | −1,501−65.3% | Reduced |
| EverSource Wealth Advisors, LLC | 345 | $524 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 287 | $436 | 0.00% | −62−17.8% | Reduced |
| US Bancorp | 228 | $347 | 0.00% | +228 | New |
| SBI Securities Co., Ltd. | 74 | $112 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −177,377−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −58,349−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −32,650−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −17,421−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −13,914−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −12,073−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −11,705−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −659−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −63,740−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −16−100.0% | Sold out |